A robust mean and variance test with application to high-dimensional phenotypes.

ALSPAC ARIES DNA methylation Joint location-and-scale test Variability test

Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 17 11 2020
accepted: 06 09 2021
pubmed: 16 10 2021
medline: 15 6 2022
entrez: 15 10 2021
Statut: ppublish

Résumé

Most studies of continuous health-related outcomes examine differences in mean levels (location) of the outcome by exposure. However, identifying effects on the variability (scale) of an outcome, and combining tests of mean and variability (location-and-scale), could provide additional insights into biological mechanisms. A joint test could improve power for studies of high-dimensional phenotypes, such as epigenome-wide association studies of DNA methylation at CpG sites. One possible cause of heterogeneity of variance is a variable interacting with exposure in its effect on outcome, so a joint test of mean and variability could help in the identification of effect modifiers. Here, we review a scale test, based on the Brown-Forsythe test, for analysing variability of a continuous outcome with respect to both categorical and continuous exposures, and develop a novel joint location-and-scale score (JLSsc) test. These tests were compared to alternatives in simulations and used to test associations of mean and variability of DNA methylation with gender and gestational age using data from the Accessible Resource for Integrated Epigenomics Studies (ARIES). In simulations, the Brown-Forsythe and JLSsc tests retained correct type I error rates when the outcome was not normally distributed in contrast to the other approaches tested which all had inflated type I error rates. These tests also identified > 7500 CpG sites for which either mean or variability in cord blood methylation differed according to gender or gestational age. The Brown-Forsythe test and JLSsc are robust tests that can be used to detect associations not solely driven by a mean effect.

Identifiants

pubmed: 34651232
doi: 10.1007/s10654-021-00805-w
pii: 10.1007/s10654-021-00805-w
pmc: PMC9187575
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

377-387

Subventions

Organisme : Medical Research Council
ID : MC_UU_00011/4
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBI025751/1
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/I025263/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12013/9
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M025020/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : NIAID NIH HHS
ID : R01 AI121226
Pays : United States
Organisme : CONTAMED EU Collaborative Project
ID : 212502
Organisme : Wellcome Trust
ID : 102215/2/13/2
Pays : United Kingdom
Organisme : National Institute of Child and Human Development
ID : R01HD068437
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIH HHS
ID : 5RO1AI121226-02
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/5
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00011/3
Pays : United Kingdom
Organisme : NICHD NIH HHS
ID : R01 HD068437
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Int J Epidemiol. 2015 Aug;44(4):1181-90
pubmed: 25991711
Trends Mol Med. 2014 Oct;20(10):541-3
pubmed: 25092140
J Clin Epidemiol. 2018 Jun;98:146-151
pubmed: 29258908
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Genet Epidemiol. 2014 Jan;38(1):51-59
pubmed: 24482837
Bioinformatics. 2012 Jun 1;28(11):1487-94
pubmed: 22492641
Epigenomics. 2011 Dec;3(6):771-84
pubmed: 22126295
Epigenetics Chromatin. 2015 Oct 19;8:43
pubmed: 26500701
Genome Biol. 2014 Dec 03;15(12):503
pubmed: 25599564
PLoS Genet. 2007 Sep;3(9):1724-35
pubmed: 17907809
Sci Adv. 2019 Aug 14;5(8):eaaw3538
pubmed: 31453325
Genome Res. 2015 Mar;25(3):338-52
pubmed: 25650246
Hum Mol Genet. 2018 Mar 1;27(5):799-810
pubmed: 29325024
Clin Epigenetics. 2015 Sep 11;7:95
pubmed: 26366232
Nat Genet. 2018 Nov;50(11):1608-1614
pubmed: 30323177
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Biometrics. 2017 Sep;73(3):960-971
pubmed: 28099998
Am J Hum Genet. 2015 Jul 2;97(1):125-38
pubmed: 26140448
Cold Spring Harb Perspect Med. 2022 Jan 4;12(1):
pubmed: 34426474
Int J Epidemiol. 2003 Feb;32(1):1-22
pubmed: 12689998
Pac Symp Biocomput. 2013;:69-79
pubmed: 23424113
Proc Natl Acad Sci U S A. 2010 Jan 26;107 Suppl 1:1757-64
pubmed: 20080672
JAMA Psychiatry. 2019 Oct 1;76(10):1063-1073
pubmed: 31158853
Epigenetics. 2014 Oct;9(10):1382-96
pubmed: 25424692
Int J Epidemiol. 2011 Jun;40(3):537-62
pubmed: 21807641
Methods Mol Biol. 2015;1238:51-63
pubmed: 25421654
BMC Bioinformatics. 2016 Apr 22;17:178
pubmed: 27103033
Nat Rev Genet. 2004 Nov;5(11):826-37
pubmed: 15520792
Int J Epidemiol. 2013 Feb;42(1):97-110
pubmed: 22507742
Genome Res. 2014 Nov;24(11):1725-33
pubmed: 25249537
Genome Biol. 2016 Oct 7;17(1):207
pubmed: 27717397
BMC Bioinformatics. 2010 Nov 30;11:587
pubmed: 21118553
Bioinformatics. 2018 Dec 1;34(23):3983-3989
pubmed: 29931280
Hum Mol Genet. 2015 Apr 15;24(8):2201-17
pubmed: 25552657
BMC Bioinformatics. 2018 May 18;19(1):174
pubmed: 29776330
PLoS One. 2015 Dec 18;10(12):e0145295
pubmed: 26683022
BMC Genomics. 2015 Nov 09;16:911
pubmed: 26553366

Auteurs

James R Staley (JR)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.

Frank Windmeijer (F)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
Department of Statistics and Nuffield College, University of Oxford, Oxford, UK.

Matthew Suderman (M)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.

Matthew S Lyon (MS)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.
National Institute for Health Research Bristol Biomedical Research Centre, University of Bristol, Oakfield House, Bristol, BS8 2BN, UK.

George Davey Smith (G)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK.

Kate Tilling (K)

MRC Integrative Epidemiology Unit, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, BS8 2BN, UK. kate.tilling@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH